MGMT
Basic information
Region (hg38): 10:129467190-129770983
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MGMT gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 19 | 22 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 20 | 5 | 1 |
Variants in MGMT
This is a list of pathogenic ClinVar variants found in the MGMT region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-129467245-C-T | Likely benign (May 09, 2018) | |||
10-129467249-G-T | not specified | Uncertain significance (Nov 17, 2023) | ||
10-129467255-C-G | not specified | Uncertain significance (Dec 03, 2021) | ||
10-129467281-C-T | Glioblastoma | not provided (Mar 10, 2016) | ||
10-129536278-G-T | not specified | Uncertain significance (Sep 26, 2023) | ||
10-129536279-C-T | Uncertain significance (Feb 25, 2016) | |||
10-129536326-A-G | not specified | Uncertain significance (May 18, 2022) | ||
10-129536340-G-A | not specified | Likely benign (Dec 31, 2019) | ||
10-129536349-C-T | not specified | Uncertain significance (Aug 15, 2023) | ||
10-129707922-G-A | Likely benign (Nov 03, 2018) | |||
10-129707936-C-T | not specified | Uncertain significance (Feb 13, 2024) | ||
10-129707992-G-A | not specified | Uncertain significance (Dec 08, 2021) | ||
10-129708007-C-G | not specified | Uncertain significance (Jun 01, 2023) | ||
10-129708010-G-A | not specified | Uncertain significance (Mar 24, 2023) | ||
10-129708014-C-T | not specified | Uncertain significance (Jul 09, 2021) | ||
10-129708026-A-G | not specified | Uncertain significance (Mar 29, 2022) | ||
10-129708030-C-T | Likely benign (Dec 31, 2019) | |||
10-129759211-C-G | not specified | Uncertain significance (Jan 26, 2022) | ||
10-129759214-G-A | not specified | Uncertain significance (Dec 16, 2023) | ||
10-129759304-C-G | not specified | Uncertain significance (Oct 06, 2023) | ||
10-129766794-A-G | not specified | Uncertain significance (Dec 26, 2023) | ||
10-129766830-G-A | not specified | Uncertain significance (Jan 26, 2023) | ||
10-129766873-G-C | not specified | Uncertain significance (Sep 16, 2021) | ||
10-129766906-A-G | Benign (Oct 07, 2019) | |||
10-129766915-T-C | not specified | Uncertain significance (Jun 23, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MGMT | protein_coding | protein_coding | ENST00000306010 | 5 | 300824 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.18e-7 | 0.109 | 125726 | 0 | 22 | 125748 | 0.0000875 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.623 | 165 | 144 | 1.15 | 0.00000865 | 1482 |
Missense in Polyphen | 50 | 47.677 | 1.0487 | 513 | ||
Synonymous | -0.992 | 78 | 67.6 | 1.15 | 0.00000490 | 513 |
Loss of Function | -0.342 | 10 | 8.90 | 1.12 | 3.81e-7 | 104 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000185 | 0.000185 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000124 | 0.000123 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.0000656 | 0.0000653 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in the cellular defense against the biological effects of O6-methylguanine (O6-MeG) and O4-methylthymine (O4-MeT) in DNA. Repairs the methylated nucleobase in DNA by stoichiometrically transferring the methyl group to a cysteine residue in the enzyme. This is a suicide reaction: the enzyme is irreversibly inactivated.;
- Pathway
- Busulfan Pathway, Pharmacodynamics;Cyclophosphamide Pathway, Pharmacodynamics;DNA Repair;MGMT-mediated DNA damage reversal;DNA Damage Reversal
(Consensus)
Recessive Scores
- pRec
- 0.553
Intolerance Scores
- loftool
- 0.823
- rvis_EVS
- 0.62
- rvis_percentile_EVS
- 83.25
Haploinsufficiency Scores
- pHI
- 0.0515
- hipred
- N
- hipred_score
- 0.438
- ghis
- 0.397
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.572
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mgmt
- Phenotype
- respiratory system phenotype; neoplasm; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype;
Gene ontology
- Biological process
- DNA ligation;DNA repair;DNA methylation;DNA dealkylation involved in DNA repair;cellular response to oxidative stress;negative regulation of apoptotic process;regulation of cysteine-type endopeptidase activity involved in apoptotic process;response to ethanol;response to folic acid;mammary gland epithelial cell differentiation;cellular response to organic cyclic compound;cellular response to ionizing radiation;positive regulation of double-strand break repair
- Cellular component
- nucleus;nucleoplasm;membrane
- Molecular function
- DNA binding;methylated-DNA-[protein]-cysteine S-methyltransferase activity;calcium ion binding;methyltransferase activity;DNA-methyltransferase activity